Work

Chelating [227Th]Th4+ for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors

Year: 2025

Type: article

Source: Bioconjugate Chemistry

DOI: 10.1021/acs.bioconjchem.5c00129

Authors: Luke Wharton, Scott W. McNeil, Harrison Meeres, Diduo Zhang, Aidan Ingham, Helen Merkens, Maryam Osooly, Cristina Rodríguez-Rodríguez, François Bénard, Hua Yang

Institutions: TRIUMF, University of British Columbia, Simon Fraser University

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, National Research Council Canada

Awards: G5918855451, Production and chelation chemistry of radiolanthanides

OpenAlex ID: W4410259304

FWCI: 3.167

Cites: 44

Cited by: 6

Related to: 10